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VL.01 ROBOTIC RESECTION OF
CHOLEDOCHAL CYST WITH
HEPATICODUODENOSTOMY
S. G. Warner and K. T. Nguyen
University Of Michigan, Division Of HPB And Advanced
GI Surgery, Ann Arbor, MI
Introduction: Resection of the common bile duct is the
treatment of choice for type I choledochal cysts found in
adults. The procedure can portend a significant morbidity
because of the large incision required for adequate exposure.
Robotic surgery provides excellent visualization and fine
manipluation of the biliary system with minimized morbidity
to the patient.
Methods: A 26 yr old female required excision of large type
I choledochal cyst. The Da Vinci Si Robot System (Intuitive
Surgical, Sunnyvale, CA) was utilized to assist resection.
Results: Port placement was similar to standard robotic
cholecystectomy ports, with slight alterations to facilitate
possible roux-en-Y hepaticojejunostomy in case a
hepaticoduodenostomy was not possible. Operative time was
less than 210 minutes, estimated blood loss was 100 mL.
Aberrant anatomy was identified in that the right anterior
bile duct coursed over the right posterior bile duct before
inserting separately from the common hepatic duct conflu-
ence into the choledochal cyst. The common bile duct was
dissected to the level of the pancreatic parenchyma and then
ligated using hem-o-lok clips (Teleflex Medical, Research
Triangle, NC). The hepaticoduodenostomy was constructed
using 3-0 vicryl sutures with a running back wall and an
interrupted front wall. The patient progressed well post-
operatively and was discharged home post-operative day four
after an uncomplicated hospital course.
Conclusion: Robotic resection of choledochl cyst with
hepaticoduodenostomy is a feasible technique that confers
the advantages over open technique such as fine movements,
superior visualization and improved post-operative pain and
return to function.
VL.02 ROBOTIC SEGMENTAL
DUODENAL RESECTION
R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram,
D. A. Iannitti and J. B. Martinie
Carolinas Medical Center, Charlotte, NORTH CAROLINA
Background: Duodenal polyps can have malignant poten-
tial and hence warrant a biopsy and subsequent resection if
needed. Most of them can be done endoscopically but some
warrant a surgical resection.
Introduction: We present a 69 year old female with a 3 cm
intramural lesion on the lateral wall of the 2nd portion of the
duodenum. Her primary clinical presentation was upper GI
bleeding. The endoscopic biopsy was consistent with a
myofibroblastic lesion with ulceration. We decided to
proceed with a robotic sleeve resection of the lesion.
Method: After trocar placement, the hepatic flexure of the
colon was taken down using monopolar scissors to visualize
the duodenum. A complete kocker maneuver was performed
and the lesion was identified. Intraoperative ultrasound was
performed to confirm the location. We used the monopolar
electrocautery scissors to make a duodenotomy along the
anteromedial aspect. We then proceeded to create an ellipse
around the polyp until it completely free of the remaining
duodenum. Frozen section was consistent with a benign
inflammatory fibrous polyp. The segmental duodenal resec-
tion was closed using running lambert sutures using two
40 V LOC suture. At completion we checked for hemostasis
and a 19 French blake drain was placed over the area of the
repair. The patient tolerated the procedure well and was dis-
charged 3 days later.
Conclusion: We present a novel minimally invasive
approach for segmental duodenal resection that would
decrease the overall morbidity and mortality of the procedure
and promote early recovery.
VL.03 LAPAROSCOPIC RIGHT
HEPATECTOMY WITH HYDROJET AND
HARMONIC SCALPEL DISSECTION
J. B. Conneely, R. Smoot and S. Cleary
Toronto General Hospital, Tornto, ONTARIO
The increasing availability of laparoscopic energy devices for
vessel sealing and division has been a boon to laparoscopic
surgeons worldwide. Liver resection in particular has been
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aided by the improved performance and evolving ergonomics
of these devices. The Hydrojet dissector has proven to be of
enormous benefit in open liver resection. It allows precise
parenchymal dissection and clear exposure of even the small-
est vessels and biliary radicles. Its adoption in open surgery
has been somewhat limited, with the established technologies
of CUSA, bipolar electrocautery and ultrasonic technology
enjoying more widespread adoption. In laparoscopic liver
surgery, few centres routinely employ the Hydrojet. Our insti-
tution routinely employs Hydrojet for live donor hepatectomy
and as such we have extensive experience with the device. We
have employed Hydrojet regularly for laparoscopic hepatec-
tomy and describe herein our technique of parenchymal divi-
sion during major hepatectomy, combining the benefits of
the Hydrojet and the Harmonic Scalpel. We demonstrate the
precise parenchymal dissection made possible by the
laparoscopic Hydrojet. We propose that this technique of liver
resection is safe, efficient and precise.
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LO-A.01 LAPAROSCOPIC
HEPATECTOMY SIGNIFICANTLY
SHORTENS THE TIME TO
POSTOPERATIVE CHEMOTHERAPY IN
OBESE PATIENTS UNDERGOING MAJOR
HEPATECTOMIES
S. C. Agle, P. Philips, M. E. Egger, C. R. Scoggins,
K. M. McMasters and R. C. Martin
University Of Louisville, Louisville, KY
Background and Objectives: The multimodality manage-
ment of resectable hepatic malignancies commonly utilizes
chemotherapy either in a pre-operative/post-operative or
post-operative delivery. The benefit of post-operative chemo-
therapy occurs with early initiation, but is commonly delayed
due to procedural related complications. Minimally invasive
surgery in the obese population is known to significantly
reduce complications, length of stay (LOS) and earlier to
return to baseline. The aim of this study was to compare open
versus laparoscopic surgical approaches to major liver resec-
tion in obese patients.
Methods: We performed a single center retrospective
review of 118 consecutive patients with a BMI ≥25, a diag-
nosis of cancer, underwent a major hepatectomy (>3 seg-
ments) from 2007 through 2012 with planned post-operative
chemotherapy.
Results: A matched group of 42 laparoscopic were com-
pared to 76 open cases having equivalent resections based on
tumor location and diagnosis. There were no differences in
the past medical/surgical history, surgical procedure, and
30-day mortality. The open cohort had more blood loss (475
vs 250 ml p = <0.001), longer LOS (Median 6.5 vs 4.0 days,
p = <0.001) and a prolonged time to post-operative chemo-
therapy initiation (37 vs 24 days, p = <0.001). On multivari-
ate analysis laparoscopic resection was found to be an
independent predictor of a shorter LOS and earlier initiation
of postoperative chemotherapy.
Conclusion: The benefits of laparoscopic major
hepatectomies in the obese population included a shorter
length of stay and earlier initiation of chemotherapy com-
pared to the open group. These benefits were seen without
jeopardizing surgical margins or extent of resection with
associated improved outcomes.
LO-A.02 SURVIVAL ANALYSIS OF
PATIENTS WITH STAGE I AND II
HEPATOCELLULAR CARCINOMA
FOLLOWING LIVER
TRANSPLANTATION AND LIVER
RESECTION
R. M. Seshadri, D. J. Niemeyer, R. Z. Swan, D. Sindram,
J. B. Martinie, M. Russo and D. A. Iannitti
Carolinas Medical Center, Charlotte, NORTH CAROLINA
Introduction: Liver transplantation (LT) is a treatment
option in select patients with hepatocellular carcinoma
(HCC). We compared survival in patients with HCC who had
a transplant versus liver resection based on AJCC clinical
stage.
Method: The study is a retrospective analysis from the
Commission on Cancer’s National Cancer Data Base
(NCDB) between the years 1998–2011. 148,882 patients
with liver cancer were identified, of which 126,858 had HCC.
64,227 patients from 1998–2006 had 5-year survival data.
Patients were stratified by AJCC clinical stage I and II, and
resection was compared to LT. The study was limited to stage
I and II patients as most would fit Milan Criteria for trans-
plantation. Kaplan-Meier curves and log rank tests were used
for statistical analysis.
Results: 3,194 HCC patients met the analysis criteria. Mean
age in the LT group and resection group was 56 and 63
respectively. Among stage I HCC, 839 had LT and 823 had a
liver resection. Among stage II HCC, 806 had LT and 726
had liver resection. In the stage I group, median survival for
LT and resection was 127.9 and 54.1 months respectively
(p < 0.0001), and in the stage II group the median survival
was 111.8 and 41.8 months (p < 0.0001). Resection patients
with stage I HCC had a longer median survival than stage II
patients (p = 0.0002), however there was no significant dif-
ference in the LT group.
Conclusion: Liver transplantation offers a survival advan-
tage compared to resection among patients with AJCC clini-
cal stage I and II HCC.
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